RVRC REVIUM Rx.
Fundamentals / CIK 0001839140 / USDREVIUM Rx. reported $7.11M in total assets and a net loss of $13.45M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RVRC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-- Operating profit
-
Net Income FY 2025-$13.45M GAAP bottom line
-
Diluted EPS FY 2025-$0.22 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$842K Total debt: $128K
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 |
|---|---|
| Income Tax Expense | $358K |
| Net Income | -$13.45M |
| Basic EPS | -$0.22 |
| Diluted EPS | -$0.22 |
| Basic Shares Outstanding | 60.7M |
| Diluted Shares Outstanding | 60.7M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Research & Development | $443K | $473K | $391K | $218K |
| Operating Income | -$732K | -$739K | -$938K | -$737K |
| EBITDA | -$732K | -$737K | -- | -- |
| Net Income | -$748K | -$725K | -$1.04M | -$634K |
| Basic EPS | $0.01 | $0.01 | $0.02 | $0.01 |
| Diluted EPS | $0.01 | $0.01 | $0.02 | $0.01 |
| Basic Shares Outstanding | 60.7M | 60.7M | 60.7M | 60.7M |
| Diluted Shares Outstanding | 60.7M | 60.7M | 60.7M | 60.7M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $1.68M | $3.27M |
| Cash & Short-Term Investments | $1.68M | $3.27M |
| Other Current Assets | $375K | $238K |
| Total Current Assets | $3.10M | $5.52M |
| Property, Plant & Equipment, Net | $10K | $9.0K |
| Goodwill | $2.58M | $11.41M |
| Intangible Assets | $2.50M | $3.34M |
| Total Non-Current Assets | $5.21M | $14.77M |
| Total Assets | $8.30M | $20.28M |
| Accounts Payable | $163K | $142K |
| Total Current Liabilities | $799K | $576K |
| Total Non-Current Liabilities | $621K | $0 |
| Total Liabilities | $1.42M | $576K |
| Total Debt (incl. Leases) | $106K | -- |
| Common Stock | $61K | $61K |
| Retained Earnings | -$24.96M | -$11.51M |
| Total Stockholders' Equity | $6.88M | -- |
| Total Equity | $6.88M | $19.71M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $842K | $920K | $1.68M | $3.27M |
| Cash & Short-Term Investments | $842K | $920K | $1.68M | $3.27M |
| Other Current Assets | $341K | $334K | $375K | $238K |
| Total Current Assets | $1.86M | $2.48M | $3.10M | $5.52M |
| Property, Plant & Equipment, Net | $9.0K | $9.0K | $10K | $9.0K |
| Goodwill | $2.58M | $2.58M | $2.58M | $11.41M |
| Intangible Assets | $2.50M | $2.50M | $2.50M | $3.34M |
| Total Non-Current Assets | $5.25M | $5.27M | $5.21M | $14.77M |
| Total Assets | $7.11M | $7.75M | $8.30M | $20.28M |
| Accounts Payable | $620K | $231K | $163K | $142K |
| Total Current Liabilities | $971K | $1.53M | $799K | $576K |
| Total Non-Current Liabilities | $619K | $67K | $621K | $0 |
| Total Liabilities | $1.59M | $1.60M | $1.42M | $576K |
| Total Debt (incl. Leases) | $128K | $151K | $106K | -- |
| Common Stock | $61K | $61K | $61K | $61K |
| Retained Earnings | -$26.43M | -$25.69M | -$24.96M | -$11.51M |
| Total Stockholders' Equity | $5.52M | $6.16M | $6.88M | -- |
| Total Equity | $5.52M | $6.16M | $6.88M | $19.71M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 |
|---|---|
| Net Income | -$13.45M |
| Stock-Based Compensation | $624K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net Income | -$748K | -$725K | -$1.04M | -$634K |
| Depreciation & Amortization | $0 | $2.0K | -- | -- |
| Stock-Based Compensation | $111K | -- | $154K | $340K |
| Change in Payables | $389K | $68K | $52K | -$5.0K |
| Operating Cash Flow | -$626K | -$541K | -$759K | -$357K |
| Purchases of Investments | -$1.0K | -$18K | -- | -- |
| Investing Cash Flow | $548K | -$217K | $496K | $1.00M |
| Net Change in Cash | -$78K | -$758K | -$263K | $643K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 |
|---|---|
| Return on Equity (ROE) | -195.5% |
| Return on Assets (ROA) | -162.0% |
| Current Ratio | 3.87x |
| Quick Ratio | 2.10x |
| Debt to Equity | 0.02x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Current Ratio | 1.91x | 1.62x | -- | -- |
| Quick Ratio | 0.87x | 0.60x | -- | -- |
| Debt to Equity | 0.02x | 0.02x | -- | -- |
| EPS Growth (YoY) | -50.0% | 0.0% | -- | -- |